Racial Differences in Survival among Men with Prostate Cancer and Comorbidity at Time of Diagnosis

American Journal of Public Health

Volumn 94, Issue 5, 2004, Pages 803-808

  Freeman, Vincent L ^a,b   Durazo Arvizu, Ramon ^c   Keys, LaShon C ^d   Johnson, Marc P ^b   Schafernak, Kristian ^b   Patel, Vikas K ^b  

^a HINES VA HOSPITAL   (United States)

^b LOYOLA UNIVERSITY CHICAGO   (United States)

^c NORTHWESTERN UNIVERSITY   (United States)

^d Illinois Department of Human Services   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGE; ARTICLE; CANCER DIAGNOSIS; CANCER RISK; CANCER STAGING; CANCER SURVIVAL; CANCER THERAPY; CAUCASIAN; COMORBIDITY; CONTROLLED STUDY; DEMOGRAPHY; HUMAN; MAJOR CLINICAL STUDY; MALE; NEGRO; PROSTATE CANCER; RACE DIFFERENCE; UNITED STATES;

EID: 2342442245     PISSN: 00900036     EISSN: None     Source Type: Journal    
DOI: 10.2105/AJPH.94.5.803     Document Type: Article

References (28)

1. Stanford JL, Stephenson RA, Coyle LM, et al. Prostate Cancer Trends 1973-1995. SEER Program. National Institutes of Health Publication 99-4543. Bethesda, Md: National Cancer Institute; 1999.
2. Merrill RM, Brawley OW. Prostate cancer incidence and mortality rates among whites and black men. Epidemiology. 1997;8:126-131.
3. Makridakis N, Ross RK, Pike MC, et al. Association of mis-sense substitution in SDR5A2 gene with prostate cancer in African-American and Hispanic men in Los Angeles, USA. Lancet. 1999;354:975-978.
4. Jepson C, Kessler LG, Portnoy B, Gibbs T. Black-white differences in cancer prevention knowledge and behavior. Am J Public Health. 1991;81:501-504.
5. Myers RE, Wolf TA, Balshem AM, Ross EA, Chodak GW. Receptivity of African-American men to prostate cancer screening. Urology 1994;43:480-487.
6. Harlan L, Brawley O, Pommerenke F, Wall P, Kramer B. Geographic, age and racial variation in the treatment of local/regional carcinoma of the prostate. J Clin Oncol. 1995;13:93-100.
7. Blendon RJ, Aiken LH, Freeman HE, Corey CR. Access to medical care for black and white Americans: a matter of cost concern. JAMA. 1989;261:278-281.
8. Pienta KJ, Demers R, Hoff M, Kau TY, Montie JE, Severson RK. Effect of age and race on the survival of men with prostate cancer in the metropolitan Detroit tri-county area, 1973-1987. Urology. 1995;45:93-101.
9. Powell IJ, Schwartz K, Hussain M. Removal of the financial barrier to health care: does it impact on prostate cancer at presentation and survival? A comparative study between black and white men in a Veteran's Affairs system. Urology. 1995;46:825-830.
10. National Center for Chronic Disease Prevention and Health Promotion. Chronic Disease in Minority Populations. Atlanta, Ga: Centers for Disease Control and Prevention; 1992.
11. Albertsen PC, Fryeback DG, Storer BE, Kolon TF, Fine J. Long-term survival among men with conservatively treated prostate cancer. JAMA. 1995;274: 626-631.
12. Sweat SD, Bergstralh EJ, Slezak J, Blute ML, Zincke H. Competing risk analysis after radical prostatectomy for clinically nonmetastatic prostate adenocarcinoma according to clinical Gleason score and patient age. J Urol. 2002;168:525-529.
13. American Cancer Society and the National Comprehensive Cancer Network. Prostate Cancer Treatment Guidelines for Patients (Version III, October 2002). Available at: http://www.nccn.org. Accessed March 21, 2004.
14. US Census Bureau. 1990 Census of Population-Social and Economic Characteristics. Washington, DC: US Dept of Commerce; 1993. Publication CP-2.
15. International Classification of Diseases, 9th Revision, Clinical Modification. Geneva, Switzerland: World Health Organization; 1980.
16. Gleason DF. Histologic grading of and staging of prostatic carcinoma. In: Tannenbaum M, ed. Urologic Pathology: The Prostate. Philadelphia, Pa: Lea & Febiger; 1977: 171-197.
17. American Joint Committee on Cancer. AJCC Cancer Staging Manual. 5th ed. Philadelphia, Pa: Lippincott-Raven; 1997.
18. Schmidt JD, Mettlin CJ, Natarajan N, Peace BB, Beart RS Jr, Winchester DP. Trends in patterns of care for prostatic cancer 1974-1983: results of surveys by the American College of Surgeons. J Urol. 1987;136: 416-421.
19. Natarajan N, Murphy GP, Mettlin C. Prostate cancer in blacks: an update from the American College of Surgeon's pattern of care studies. J Surg Oncol. 1989; 40:232-236.
20. Charlson ME, Pompei P, Alex KL, MacKenzi CR. A new method of classifying prognostic co-morbidity in longitudinal studies: development and validation. J Chronic Dis. 1987;40:373-383.
21. Fisher SG, Weber L, Golber J, Davis F. Mortality ascertainment in the veteran population: alternatives to the National Death Index. Am J Epidemiol. 1995;141: 242-250.
22. International Classification of Diseases, 9th Revision. Geneva, Switzerland: World Health Organization; 1980.
23. Kalbfleisch JD, Prentice RL. The Statistical Analysis of Failure Time Data. New York, NY: Wiley; 1980.
24. Efron B, Tibshirani RJ. An Introduction to the Bootstrap. New York, NY: Chapman & Hall; 1993.
25. Therneau TM, Grambsch PM. Modeling Survival Data. Extending the Cox Model. New York, NY: Springer; 2000.
26. Stata Statistical Software: Release 7.0 [computer program]. College Station, Tex: Stata Corp; 2001.
27. Smedley BD, Stith AY, Nelson AR, eds. Unequal Treatment: Confronting Racial and Ethnic Disparities in Health Care. Washington, DC: National Academy Press; 2002.
28. Committee on Quality of Health Care in America, Institute of Medicine. Crossing the Quality Chasm: A New Health Care System for the 21st Century. Washington, DC: National Academy Press; 2001.